B. Metzler seel. Sohn & Co. AG

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1847838 FRANKFURT, 2M

Position in ARWR

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,146,810

+$495,418 QoQ

Shares Held

26,338

0.0% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#192

of 497 holders

Holding Since

Mar 2022

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

B. Metzler seel. Sohn & Co. AG holds $150,123,352 across 18 Biotechnology names. ARWR ranks #10 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	231,381	$114,933,882
2	INSM	INSMED Inc	40,521	$4,320,349
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,591	$3,188,207
4	DNLI	Denali Therapeutics Inc.	112,300	$2,888,356
5	REGN	Regeneron Pharmaceuticals, Inc.	4,472	$2,788,470
6	RVMD	Revolution Medicines, Inc.	13,605	$2,547,944
7	AXSM	Axsome Therapeutics, Inc.	9,241	$2,261,919
8	TECH	BIO-TECHNE Corp	31,091	$2,196,579

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,146,810	26,338	0.0%	Shares	Defined	2026-08-11
2026-03-31	$1,651,392	26,338	+27.3%	Shares	Defined	2026-05-08
2025-12-31	$1,373,941	20,695	+10.6%	Shares	Defined	2026-01-28
2024-09-30	$362,315	18,705	0.0%	Shares	Defined	2024-11-08
2024-06-30	$486,142	18,705	0.0%	Shares	Defined	2024-08-13
2024-03-31	$534,963	18,705	0.0%	Shares	Defined	2024-05-15
2023-12-31	$572,373	18,705	+82.2%	Shares	Defined	2024-02-13
2022-03-31	$472,225	10,268	—	Shares	Defined	2022-05-10
No filing history on record for this holder in this stock.